1. Home
  2. XLO vs AP Comparison

XLO vs AP Comparison

Compare XLO & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • AP
  • Stock Information
  • Founded
  • XLO 2016
  • AP 1929
  • Country
  • XLO United States
  • AP United States
  • Employees
  • XLO N/A
  • AP N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • AP Fluid Controls
  • Sector
  • XLO Health Care
  • AP Industrials
  • Exchange
  • XLO Nasdaq
  • AP Nasdaq
  • Market Cap
  • XLO 40.9M
  • AP 44.5M
  • IPO Year
  • XLO 2021
  • AP N/A
  • Fundamental
  • Price
  • XLO $0.82
  • AP $2.25
  • Analyst Decision
  • XLO Buy
  • AP
  • Analyst Count
  • XLO 2
  • AP 0
  • Target Price
  • XLO $3.00
  • AP N/A
  • AVG Volume (30 Days)
  • XLO 469.6K
  • AP 51.9K
  • Earning Date
  • XLO 11-07-2025
  • AP 11-12-2025
  • Dividend Yield
  • XLO N/A
  • AP N/A
  • EPS Growth
  • XLO N/A
  • AP N/A
  • EPS
  • XLO N/A
  • AP N/A
  • Revenue
  • XLO $15,001,000.00
  • AP $414,471,000.00
  • Revenue This Year
  • XLO $519.70
  • AP N/A
  • Revenue Next Year
  • XLO $44.57
  • AP N/A
  • P/E Ratio
  • XLO N/A
  • AP N/A
  • Revenue Growth
  • XLO 536.45
  • AP N/A
  • 52 Week Low
  • XLO $0.62
  • AP $1.61
  • 52 Week High
  • XLO $1.70
  • AP $3.99
  • Technical
  • Relative Strength Index (RSI)
  • XLO 57.82
  • AP 46.19
  • Support Level
  • XLO $0.73
  • AP $2.23
  • Resistance Level
  • XLO $0.85
  • AP $2.35
  • Average True Range (ATR)
  • XLO 0.05
  • AP 0.16
  • MACD
  • XLO 0.00
  • AP 0.03
  • Stochastic Oscillator
  • XLO 65.97
  • AP 68.32

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: